Sanjaya Singh

Sanjaya Singh is a distinguished scientist and entrepreneur currently serving as Chief Scientific Officer and Founder of Third Arc Bio since January 2022, while simultaneously holding the position of Venture Partner at Omega Funds and Co-Founder and Scientific Advisory Board member at Aliada Therapeutics. Previously, Sanjaya Singh held notable roles at The Janssen Pharmaceutical Companies of Johnson & Johnson as Vice President and Global Head of Janssen Biotherapeutics, and at Boehringer Ingelheim, progressing from Director to Vice President in Biotherapeutics Discovery. Sanjaya Singh began career at Tanox, Inc. as Director of Antibody Discovery and has extensive experience at MD Anderson Cancer Center as a Postdoctoral Fellow and Research Associate. Sanjaya Singh earned a PhD in Zoology from Banaras Hindu University.